1Gunter MJ, Hoover DR, Yu H,et al. Insulin, insulin-likegrowth factor-1 ,and risk of breast cancer in postmenopausal women. JNatl Cancer Inst 2009; 101 (1) :48-60.
2Becker S ,Dossus L, Kaaks R. Obesity related hyperinsulinae-mia and hyperglycaemia and cancer development. Arch Physiol Bio-chem 2009;115(2) ;86-96.
3Zhou J,Li H,Ran X,et al. Reference values for continuousglucose monitoring in Chinese subjects. Diabetes Care 2009;32(7):1188-93.
4Erbel S, Reers C, Eckstein VW, et al. Proliferation of colo-357 pancreatic carcinoma cells and survival of patients with pancreaticcarcinoma are not altered by insulin glargine. Diabetes Care 2008 ; 31(6):1105-1111.
5Colhoun HM, SDRN Epidemiology Group. Use of insulinglargine and cancer incidence in Scotland : a study from the Scottish Di-abetes Research Network Epidemiology Group. Diabetologia 2009 ;52(9) :1755-1765.
6Dejgaard A,Lynggaard H,Rastam J,et al. No evidence of in-creased risk of malignancies in patients with diabetes treated with insu-lin detemir:a meta-analysis. Diabetologia 2009;52(12) : 2507-2512.
7Home PD, Lagarenne P. Combined randomised controlled trialexperience of malignancies in studies using insulin glargine. Diabetolo-gia 2009;52(12) :2499-2506.
9Hirsch HA,Hiopoulos D,Tsichlis PN,et al. Metformin selec-tively targets cancer stem cells,and acts together with chemotherapy toblock tumor growth and prolong remission. Cancer Res 2009 ; 69(19) :7507-7511.
10Wentholt IM,Hoekstra JB,Zwart A,et al. Pendra goes Dutch:lessons for the CE mark in Europe. Diabetologia 2005 ;48(6) :1055-8.
4Mohan LR,Mohan V. Drug induced diabetes mellitus[J].J Assoc-Physicians India, 1997,45:876 - 879.
5Geetha A, Lali VS, Hussian BM, et al. Insulin-dependent diabetes mellitus induced by chemotherapy and granulocyt-macrophage colony stimulating factor[J] .J Assoc Physicians India, 1997,47:835.
